CVE-2025-61940 json
Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
published 11mo ago modified last mo. also EUVD-2025-200322
- cvss
- 8.3
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 28%
- public exploits
- 0
- none known
Summary
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Patch / fix
- Mirion Medical EC2 Software NMIS BioDose 23.0
Is CVE-2025-61940 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerVendor advisories
What the vendors themselves say about their products: affected, fixed or not affected, and what to do.
cisa ICSMA-25-336-01 updated cvss 8.3
Mirion Medical EC2 Software NMIS BioDose
-
Mirion Medical EC2 Software NMIS BioDose <23.0affected: mitigation
From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 11mo ago
Exploit prediction
0.34% chance of exploitation in the next 30 days, higher than 28% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 4.0 | 8.7 | CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N |
| CNA | 3.1 | 8.3 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L |
| CNA | 4.0 | 8.7 | CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X |
| NVD | 3.1 | 8.8 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
Affected products
- Mirion Medical EC2 Software NMIS BioDose
Classification
- Weakness
-
- CWE-603 Use of Client-Side Authentication
References
-
cisa.gov
/news-events/ics-medical-advisories/icsma-25-336-01
third-party-advisory
Sources
- CVE List CVE-2025-61940
- NVD CVE-2025-61940
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.